These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26863350)

  • 21. [Worldwide eradication of poliomyelitis].
    Rasch G; Schreier E; Kiehl W; Kurth R
    Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolving epidemiology of poliovirus serotype 2 following withdrawal of the serotype 2 oral poliovirus vaccine.
    Macklin GR; O'Reilly KM; Grassly NC; Edmunds WJ; Mach O; Santhana Gopala Krishnan R; Voorman A; Vertefeuille JF; Abdelwahab J; Gumede N; Goel A; Sosler S; Sever J; Bandyopadhyay AS; Pallansch MA; Nandy R; Mkanda P; Diop OM; Sutter RW
    Science; 2020 Apr; 368(6489):401-405. PubMed ID: 32193361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stopping a polio outbreak in the post-eradication era.
    Fine PE; Sutter RW; Orenstein WA
    Dev Biol (Basel); 2001; 105():129-47; discussion 149-50. PubMed ID: 11763322
    [No Abstract]   [Full Text] [Related]  

  • 24. Infectious disease. Vaccine-related polio outbreak in Nigeria raises concerns.
    Roberts L
    Science; 2007 Sep; 317(5846):1842. PubMed ID: 17901301
    [No Abstract]   [Full Text] [Related]  

  • 25. Vaccine-derived polioviruses and the endgame strategy for global polio eradication.
    Kew OM; Sutter RW; de Gourville EM; Dowdle WR; Pallansch MA
    Annu Rev Microbiol; 2005; 59():587-635. PubMed ID: 16153180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progress towards global interruption of wild poliovirus transmission, January 2011-March 2012.
    Wkly Epidemiol Rec; 2012 May; 87(20):195-200. PubMed ID: 24340401
    [No Abstract]   [Full Text] [Related]  

  • 27. Polio eradication: strengthening the weakest links.
    Barrett S
    Health Aff (Millwood); 2009; 28(4):1079-90. PubMed ID: 19597207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progress towards polio eradication worldwide, 2013–2014.
    Wkly Epidemiol Rec; 2014 May; 89(22):237-44. PubMed ID: 24955458
    [No Abstract]   [Full Text] [Related]  

  • 29. [From the goal of the global eradication of polio to the recent epidemics: reflections on the present epidemiological situation and future perspectives].
    Patti AM
    Ann Ig; 2010; 22(6):521-37. PubMed ID: 21425649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A world without polio.
    Cochi SL; Jafari HS; Armstrong GL; Sutter RW; Linkins RW; Pallansch MA; Kew O; Aylward RB
    J Infect Dis; 2014 Nov; 210 Suppl 1(Suppl 1):S1-4. PubMed ID: 25316822
    [No Abstract]   [Full Text] [Related]  

  • 31. [Poliomyelitis vaccine].
    Horie H
    Nihon Rinsho; 2005 May; 63 Suppl 5():601-6. PubMed ID: 15954416
    [No Abstract]   [Full Text] [Related]  

  • 32. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Problems with the oral polio vaccine.
    Bhasin VK
    Nat Med; 2008 Jan; 14(1):9. PubMed ID: 18180708
    [No Abstract]   [Full Text] [Related]  

  • 34. The polio endgame.
    Aylward B; Yamada T
    N Engl J Med; 2011 Jun; 364(24):2273-5. PubMed ID: 21675884
    [No Abstract]   [Full Text] [Related]  

  • 35. Polio outbreak threatens eradication program.
    Watanabe M
    Nat Med; 2001 Feb; 7(2):135. PubMed ID: 11175821
    [No Abstract]   [Full Text] [Related]  

  • 36. [Universal use of inactivated poliovirus vaccine--the needs and challenges].
    Shimizu H; Takeda N
    Nihon Rinsho; 2008 Oct; 66(10):1950-5. PubMed ID: 18939495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating vaccine-derived polioviruses: current state of knowledge.
    Kew OM; Wright PF; Agol VI; Delpeyroux F; Shimizu H; Nathanson N; Pallansch MA
    Bull World Health Organ; 2004 Jan; 82(1):16-23. PubMed ID: 15106296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modeling the dynamics of oral poliovirus vaccine cessation.
    Thompson KM; Duintjer Tebbens RJ
    J Infect Dis; 2014 Nov; 210 Suppl 1():S475-84. PubMed ID: 25316870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk management in a polio-free world.
    Bruce Aylward R; Sutter RW; Cochi SL; Thompson KM; Jafari H; Heymann D
    Risk Anal; 2006 Dec; 26(6):1441-8. PubMed ID: 17184391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interrupting wild poliovirus transmission using oral poliovirus vaccine: environmental surveillance in high-risks area of India.
    Chowdhary R; Dhole TN
    J Med Virol; 2008 Aug; 80(8):1477-88. PubMed ID: 18551602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.